Susan Clement Davies
Direktor/Vorstandsmitglied bei SCANCELL HOLDINGS PLC
Aktive Positionen von Susan Clement Davies
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SCANCELL HOLDINGS PLC | Direktor/Vorstandsmitglied | 24.09.2020 | - |
SCIENCE GROUP PLC | Direktor/Vorstandsmitglied | 18.05.2022 | - |
Independent Dir/Board Member | 18.05.2022 | - | |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2022 | - |
Independent Dir/Board Member | 01.01.2022 | - | |
Exploristics Ltd. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Susan Clement Davies
Ehemalige bekannte Positionen von Susan Clement Davies
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THERACRYF PLC | Direktor/Vorstandsmitglied | 01.11.2018 | 31.12.2023 |
Independent Dir/Board Member | 01.11.2018 | 31.12.2023 | |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | - | 01.01.2018 |
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Corporate Officer/Principal | - | 01.01.2018 |
Ausbildung von Susan Clement Davies
University College London | Undergraduate Degree |
London School of Economics & Political Science | Graduate Degree |
Statistik
International
Vereinigtes Königreich | 9 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 5 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
THERACRYF PLC | Health Services |
SCANCELL HOLDINGS PLC | Health Technology |
SCIENCE GROUP PLC | Commercial Services |
Private Unternehmen | 4 |
---|---|
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Finance |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Exploristics Ltd. |
- Börse
- Insiders
- Susan Clement Davies
- Erfahrung